iBot Revenue and Competitors
Estimated Revenue & Valuation
- iBot's estimated annual revenue is currently $3.6M per year.
- iBot's estimated revenue per employee is $171,500
Employee Data
- iBot has 21 Employees.
- iBot grew their employee count by 0% last year.
iBot's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & President | Reveal Email/Phone |
iBot Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.6M | 21 | 0% | N/A | N/A |
#2 | $4.5M | 26 | 8% | N/A | N/A |
#3 | $4.8M | 28 | -12% | N/A | N/A |
#4 | $5.9M | 30 | 3% | N/A | N/A |
#5 | $64.7M | 240 | 11% | N/A | N/A |
#6 | $0.1M | 1 | -97% | N/A | N/A |
#7 | $21.3M | 87 | 7% | N/A | N/A |
#8 | $6.9M | 35 | 6% | N/A | N/A |
#9 | $9M | 46 | 2% | N/A | N/A |
#10 | $1.9M | 13 | -19% | N/A | N/A |
What Is iBot?
iBot is the world's most pioneering OEM-focused provider of Internet-of-Things subsystems using a combination of electronics, sensor technology, wireless communications, telecommunications, firmware, software/cloud and cutting-edge quantum security technology. Our vision is to empower the world's top OEM's to increase revenue and to create the next generation of highly secure connected products and services. iBot is democratizing the Internet of Your Things. Watch out for iBot!
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
iBot News
In 1989 Kamen, who holds 1,000 patents including the Segway, the iBOT mobility device and AutoSyringe portable insulin pumps founded...
... including the Segway, the iBOT mobility device and the AutoSyringe, a range of portable insulin pumps that first put him on the map.
Infinity iBOT robots are easily scalable by adding more iBOTs, presentation ports, and grids. Unlike other competitive systems, the Infinity...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4M | 21 | 11% | N/A |
#2 | $3.4M | 21 | -5% | N/A |
#3 | $2.1M | 21 | 5% | N/A |
#4 | $4M | 21 | 17% | N/A |
#5 | N/A | 21 | 75% | N/A |